Viewing Study NCT06903156

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-02-24 @ 2:31 PM
Study NCT ID: NCT06903156
Status: COMPLETED
Last Update Posted: 2025-12-12
First Post: 2025-03-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)
Sponsor: Pharmasoft
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Open-Angle Glaucoma (POAG) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Glaucoma View
None Primary Open-Angle Glaucoma (POAG) View
None Glaucomatous Optic Neuropathy (GON) View
None Mitochondrial Dysfunction View
None Neuroprotection View
None Retiniprotection View
None Mexidol View
None Ethylmethylhydroxypyridine Succinate View